Walleye Trading
OPRX icon

Walleye Trading’s OptimizeRx OPRX Stock Holding History

Walleye Trading’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,200
Closed -$83.7K – 4703
2025
Q2 		$83.7K Buy
+6,200
New +$67.8K ﹤0.01% 3666
2023
Q3 		– Sell
-15,700
Closed -$224K – 5245
2023
Q2 		$224K Buy
15,700
+2,400
+18% +$34.2K ﹤0.01% 3356
2023
Q1 		$195K Buy
13,300
+3,300
+33% +$55.2K ﹤0.01% 3525
2022
Q4 		$168K Buy
+10,000
New +$173K ﹤0.01% 3701
2022
Q3 		– Sell
-1,200
Closed -$33K – 5383
2022
Q2 		$33K Buy
+1,200
New +$35.6K ﹤0.01% 4434
2022
Q1 		– Sell
-19,100
Closed -$1.19M – 5756
2021
Q4 		$1.19M Sell
19,100
-20,200
-51% -$1.53M ﹤0.01% 2083
2021
Q3 		$3.36M Buy
+39,300
New +$2.47M 0.01% 1178

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $302M AUM 117.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Walleye Trading's OPRX Position: Q3 2025 in Review

Walleye Trading sold out of OptimizeRx (OPRX) in Q3 2025, closing a stake of 9,887 shares — an estimated $133K sold.

Walleye Trading first reported a position in OPRX in Q2 2022 and held it in 2 quarters. The position peaked at $133K in Q2 2025. 125 funds tracked by Wall St. Rank hold OPRX as of Q3 2025.

  • Walleye Trading reported no remaining OptimizeRx position as of Q3 2025 after selling out during the quarter.
  • Walleye Trading sold 9,887 OptimizeRx shares in Q3 2025, an estimated $133K.
  • Walleye Trading first reported a position in OptimizeRx in Q2 2022 and held it in 2 quarters.
  • Walleye Trading's OptimizeRx position peaked at $133K in Q2 2025.
  • 125 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2025.

Based on Walleye Trading's 13F filing for Q3 2025, filed 14 Nov 2025.